CRCP
EBS icon

Copper Rock Capital Partners’s Emergent Biosolutions EBS Stock Holding History

Copper Rock Capital Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$8.62M Sell
83,374
-23,775
-22% -$2.56M 2.91% 16
2020
Q2 		$8.47M Buy
+107,149
New +$7.98M 1.46% 46

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Copper Rock Capital Partners's EBS Position: Q3 2020 in Review

Copper Rock Capital Partners reduced its Emergent Biosolutions (EBS) stake by 22% in Q3 2020, selling an estimated $2.56M and leaving 83,374 shares worth $8.62M. The position accounts for 2.91% of the portfolio, ranked #16.

Copper Rock Capital Partners first reported a position in EBS in Q2 2020 and has held it in 2 quarters since. 358 funds tracked by Wall St. Rank hold EBS as of Q3 2020.

  • Copper Rock Capital Partners held 83,374 shares of Emergent Biosolutions worth $8.62M as of Q3 2020.
  • Copper Rock Capital Partners sold 23,775 Emergent Biosolutions shares in Q3 2020, an estimated $2.56M.
  • Emergent Biosolutions made up 2.91% of Copper Rock Capital Partners's portfolio in Q3 2020, its #16 holding.
  • Copper Rock Capital Partners first reported a position in Emergent Biosolutions in Q2 2020 and has held it in 2 quarters since.
  • 358 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2020.

Based on Copper Rock Capital Partners's 13F filing for Q3 2020, filed 19 Oct 2020.